TUESDAY, Sept. 15, 2020 (Healthday News) — In a sign that Americans are becoming more wary about the safety of a new coronavirus vaccine, a new poll shows a majority of adults don’t trust what President Donald Trump has said on vaccine development. More than half (52%) of adults said they don’t trust the president’s vaccine comments, the NBC News/Survey Monkey poll found, while just 26 percent say they do. Twenty percent said they were “not aware” whether they trust what the president has said about a vaccine, NBC News reported. Those polled were also more skeptical about whether they or their families would get a government-approved coronavirus vaccine if one became widely available, NBC News reported. The poll’s latest data show that just 39% said they would get it, 23% said they wouldn’t and 36 percent say they weren’t sure. Just a month ago, 44% of Americans said they would get a government-approved vaccine, 22% said they wouldn’t, and 32% said they weren’t sure. The highest level of confidence in a coronavirus vaccine came during the week of Aug. 17 to Aug. 23, when 45% polled said they would get a vaccine. Despite public hesitancy, President Trump has promised a “safe and effective vaccine this year,” and the U.S. Centers for Disease Control and Prevention has advised states to prepare for “large-scale” vaccine distribution…  read on >

New research may have people with asthma breathing a little easier: Doctors found the airway disease doesn’t raise the risk of being hospitalized due to COVID-19. The researchers also noted that people with asthma weren’t more likely than people without it to need a ventilator to help them breathe. “A lot of people with asthma think they have a predisposition to severe COVID, and they worry a lot about going out. They should take precautions like using their masks, but they may not need to worry so much,” said study author Dr. Fernando Holguin. He’s director of the Asthma Clinical and Research Program at the University of Colorado Anschutz Medical Campus, in Aurora. Holguin said the proportion of hospitalized COVID-19 patients with asthma was around 6%. “For most places, that’s an asthma prevalence that is at or lower than the asthma prevalence in the general population. To compare, with influenza [flu], we typically see about a quarter of those in the hospital have asthma,” he said. When the pandemic first began, the U.S. Centers for Disease Control and Prevention suggested that people with asthma had a higher risk of hospitalization and other severe outcomes. People with asthma do have a significantly higher risk of complications with flu, another viral infection. In the new study, the researchers reviewed 15 studies on COVID-19 infections to see how…  read on >

Even light smokers are much more likely to die of lung disease or lung cancer than nonsmokers, a new study warns. “Everyone knows that smoking is bad for you, but it’s easy to assume that if you only smoke a little, the risks won’t be too high,” said study co-leader Pallavi Balte, of Columbia University Irving Medical Center, in New York City. The new study shows how wrong that thinking can be. It included nearly 19,000 people in the United States, average age 61, who were followed for an average of 17 years. During that time, nearly 650 died of lung disease (such as emphysema) and 560 died of lung cancer. Among nonsmokers, less than 2% died from lung disease and less than 1% died from lung cancer. But among social smokers (fewer than 10 cigarettes a day), those numbers were over 3% and close to 5%, respectively. Not surprisingly, heavy smokers (more than 20 cigarettes a day) fared worst, with more than 10% dying from lung disease and about 13% from lung cancer, the study found. After accounting for other potential factors — such as age, sex, race, level of education and body weight — the researchers concluded that social smokers were 2.5 times more likely to die of lung disease and 8.6 times more likely to die of lung cancer than nonsmokers. Social…  read on >

About 1 in 9 men will be diagnosed with prostate cancer, but experts say early detection can be a lifesaver. “Prostate cancer that is detected early, typically while it is still within the prostate gland, has a better chance of being successfully treated,” explained Dr. Alexander Kutikov, chief of the Division of Urologic Oncology at Fox Chase Cancer Center in Philadelphia. “Some types of prostate cancer are aggressive. However, most cancers are quite slow-growing, and a significant portion can be monitored without aggressive treatment,” he said in a Fox Chase news release. Men aged 55-69 should consider prostate cancer screening, the American Urological Association says. “Much debate has centered around screening for prostate cancer. Given the risks and benefits of screening, not every man should be screened for prostate cancer,” Kutikov said. “Men should talk to their health care provider about their risk factors, options and preferences. Together, they can make a decision.” In the early stages, prostate cancer usually causes no symptoms. More advanced prostate cancer may cause: difficulty urinating, including a slow or weak urinary stream or the need to urinate more often, especially at night; blood in urine or semen; pain or burning during urination; discomfort in the pelvic area; bone pain, or trouble getting an erection. “Many of these symptoms can be caused by something other than prostate cancer. However, you…  read on >

TUESDAY, Sept. 8, 2020 (Healthday News) — In a sobering illustration of the toll the coronavirus pandemic took this summer, tallies now show the number of Americans who have died of COVID-19 jumped from just under 100,000 to over 186,000 between Memorial Day and Labor Day, while cases more than quadrupled, to over 6.2 million. As troubling as those statistics are, public health experts warn the fall and winter could be even worse, the Washington Post reported. A cold-weather surge of COVID-19 cases could trigger a much-feared “second wave” of infections and deaths that begins well before Election Day in November, though scientists believe the crest of cases would come weeks later, the Post reported “My feeling is that there is a wave coming, and it’s not so much whether it’s coming but how big is it going to be,” Eili Klein, an epidemiologist at Johns Hopkins University School of Medicine in Baltimore, told the newspaper. Still, national numbers have been slowly dropping following surges that showed up in the Sun Belt in early summer, the Post reported. A model produced by the University of Washington’s Institute for Health Metrics and Evaluation (IHME) predicts a daily death toll of 1,907 on Election Day, roughly double the current number. Under the IHME forecast, the numbers would continue to rise until early December, peaking at more than…  read on >

WEDNESDAY, Sept. 9, 2020 (Healthday News) — Final testing of a leading coronavirus vaccine candidate was paused by drugmaker AstraZeneca on Tuesday after a trial volunteer experienced a serious adverse reaction. The company did not release specifics on the case, but whether the reaction was caused by the vaccine or was coincidental is still unclear, The New York Times reported. The pause, first reported by STAT, will allow for a safety review and investigation of what caused the illness. The disappointing news came as drug companies around the world race to develop a coronavirus vaccine that could bring an end to an international pandemic that has claimed almost 900,000 lives, the Times reported. AstraZeneca’s vaccine is a front-runner, with late-stage clinical trials underway in different countries. If the cause of the reaction turns out to be related to the vaccine, efforts to have it ready by the end of the year could be delayed, the Times reported. In a statement, AstraZeneca described the trial’s halt, which was done voluntarily, as a “routine action which has to happen whenever there is a potentially unexplained illness in one of the trials, while it is investigated, ensuring we maintain the integrity of the trials.” The company added that in large trials participants sometimes become sick by chance “but [the cases] must be independently reviewed to check this carefully.”…  read on >

Add a heightened risk for depression to the list of challenges facing the caregivers of loved ones who have Alzheimer’s disease. A new study found that older adults caring for spouses newly diagnosed with Alzheimer’s had a 30% increase in symptoms of depression compared to those whose spouses didn’t have Alzheimer’s or related dementia. And with care often lasting for years and Alzheimer’s symptoms continuing to worsen, those caregivers can have sustained depression for a long period of time. “We know there’s a lot of research out there on dementia and how it affects people diagnosed. But there’s not a lot of research out there looking at the emotional health of partners,” said study author Melissa Harris, a doctoral student at the University of Michigan School of Nursing. She and her team analyzed data on 16,650 older adults from the University of Michigan Health and Retirement Study. They looked at depressive symptoms over an extended period, rather than for just a snapshot in time, as had been done in previous studies. They considered individual symptoms, including feeling depressed, alone, sad and or that everything is an effort. Participants also answered whether they had felt happy in the past two weeks and whether they had felt like they enjoyed life. “The fact that we saw these depressive symptoms stay for at least two years, beyond two…  read on >

THURSDAY, Sept. 10, 2020 (Healthday News) — Just weeks into the fall semester, universities and colleges in all 50 states are now struggling to contain the spread of coronavirus on their campuses. More than 40,000 cases of COVID-19 have been reported among students, staff and faculty nationwide, CNN reported. That number is likely higher due to a lag from schools that update their data every few days. Many outbreaks have cropped up after gatherings at fraternities and sororities: One cluster of COVID-19 cases was traced back to a fraternity party held at the University of New Hampshire. More than 100 people attended the Aug. 29 party and few wore masks, CNN reported. At Indiana University Bloomington, 30 sorority and fraternity houses have been ordered to quarantine following what campus officials have described as an “alarming increase” in COVID-19 cases within the houses, CNN reported. School officials told Greek houses to suspend all in-person activities until at least Sept. 14, according to CNN. “IU’s team of public health experts is extremely concerned that Greek houses are seeing uncontrolled spread of COVID-19,” the university said in a statement. “This poses a significant risk to the nearly 2,600 students currently living in Greek or other communal housing organizations, as well as to the other 42,000 IU Bloomington students, the campus’s 12,000 faculty and staff, and the surrounding community.”…  read on >

Folks struggling with depression are much more likely to turn to marijuana to ease their symptoms these days, and that’s not necessarily a good thing, researchers report. Depressed people are more than twice as likely to have used pot within the last month and three times more likely to use it nearly every day in 2015-2016, a far higher number than 10 years before, the new study found. Experts say this boom in use among the depressed is probably linked to the spread of marijuana legalization across the United States, particularly for medical purposes. “Its accessibility has increased over the specific time period that this study measures,” noted Michael Wetter, director of adolescent and young adult medicine with the UCLA David Geffen School of Medicine. The problem is that previous studies have shown pot actually can worsen mood disorders like anxiety or depression, said Dr. Elie Aoun, assistant professor of clinical psychiatry with the Columbia University College of Physicians and Surgeons. “Marijuana does not change anything in the underlying brain pathology that contributes to depression,” Aoun said. “It just numbs your feelings so you can get through a couple of hours without thinking about your problems. When the effect dissipates, you’re going to be more depressed than you were before.” He and Wetter were not part of the research. The new study relied on data…  read on >

The coronavirus pandemic silenced choirs around the globe, but researchers in Sweden say it may be safe to sing with others if you take precautions. “There are many reports about the spreading of COVID-19 in connection with choirs singing. Therefore, different restrictions have been introduced all over the world to make singing safer,” said Jakob Löndahl, an associate professor of aerosol technology at Lund University. “So far, however, there has been no scientific investigation of the amount of aerosol particles and larger droplets that we actually exhale when we sing,” he said in a university news release. Löndahl and his colleagues wanted to gain a better understanding of the amount of aerosols (small airborne particles), droplets and coronavirus emitted when people sing. They conducted tests with 12 healthy singers and two people with confirmed COVID-19. Seven of the participants were professional opera singers. The study found that singing — particularly loud and consonant-rich singing — spreads a lot of aerosol particles and droplets into the surrounding air. According to Malin Alsved, a doctoral student of aerosol technology at the university, “Some droplets are so large that they only move a few decimeters from the mouth before they fall, whereas others are smaller and may continue to hover for minutes. In particular, the enunciation of consonants releases very large droplets and the letters B and P…  read on >